Barbara Burtness

From Wikipedia, the free encyclopedia
Barbara Ann Burtness
Academic background
EducationAB, 1982, Bryn Mawr College
MD, 1986, Stony Brook University
Academic work
InstitutionsYale University
Fox Chase Cancer Center

Barbara Ann Burtness is an American internist and oncologist. She is a Anthony N. Brady Professor of Medicine at Yale University and Chief Translational Research Officer at Yale Cancer Center. She is co-director of the Stand Up to Cancer Fanconi Anemia Research Fund-Farrah Fawcett Foundation Head and Neck Cancer Research Team.

Early life and education[edit]

Burtness completed her Bachelor of Arts degree at Bryn Mawr College in 1982 before enrolling at Stony Brook University for her medical degree. Upon graduating in 1986, she finished her internship and residency at Yale New Haven Hospital and her fellowship at the Memorial Sloan Kettering Cancer Center.[1]

Career[edit]

After completing her fellowship in 1993, Burtness became a cancer researcher at Yale University. In this role, she became a member of the Eastern Cooperative Oncology Group, a consortium of researchers who test new treatments in clinical trials.[2] Burtness remained at Yale until 2008 when she became the Chief of head and neck oncology at the Fox Chase Cancer Center.[3] During her tenure at the institution, Burtness was named one of the Best Women’s Physicians for 2011[4] and listed as one of the Best Doctors in America in 2013.[5]

Burtness left the Fox Chase Cancer Center in 2014 to return to Yale University as a Professor of Medicine and their Clinical Research Program Leader of the Head and Neck Cancers Program.[6] In this role, she was nominated for the 2018 Women Who Conquer Cancer Mentorship Award[7] and again named to the Best Doctors List.[8] During this time, she also served on various committees and councils including the Executive Committee on the Status of Women in Medicine, Faculty Advisory Council, and the Dean’s Climate Working Group. [9] In 2020, Burtness received the YCC Clinical Science Research Award in recognition of her study "Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomized, open-label, phase 3 study."[10] She serves as the co-leader of the Developmental Therapeutics Research Program at Yale Cancer Center; she is Director of the Yale Head and Neck Specialized Program in Research Excellence, awarded by the National Institutes of Health in 2020.[11]

In 2021, she was appointed Interim Associate Director for Diversity, Equity, and Inclusion at the Yale Cancer Center.[9] Burtness co-leads the multi-institutional Stand Up to Cancer Fanconi Anemia Research Fund-Farrah Fawcett Foundation Head and Neck Cancer Research Team.[12] In December 2022, she was appointed Chief Translational Research Officer and Associate Director for Translational Research at Yale Cancer Center.[13]

References[edit]

  1. ^ "Barbara Burtness, MD". Yale University. Retrieved March 27, 2022.
  2. ^ Ricks, Delthia (May 20, 2002). "Rejected Drug Shows Promise". Newsday. Retrieved March 27, 2022 – via newspapers.com.
  3. ^ "People in the news". The Philadelphia Inquirer. June 2, 2008. Retrieved March 27, 2022 – via newspapers.com.
  4. ^ Donahue, Bill (2011). "Best Women's Physicians 2011". Suburban Life. Retrieved March 27, 2022.
  5. ^ "83 Temple Physicians Named Best Doctors in America®". Temple University. February 11, 2013. Retrieved March 27, 2022.
  6. ^ "Barbara Ann Burtness, MD Appointed at Yale Cancer Center". Yale University. January 10, 2014. Retrieved March 27, 2022.
  7. ^ "Conquer Cancer Honors Winners, Nominees of 2018 Women Who Conquer Cancer Mentorship Awards". ASCO. March 30, 2018. Retrieved March 27, 2022.
  8. ^ "Over 200 Yale Medicine Physicians Make 2019 'Best Doctors' List". Yale University. June 14, 2019. Retrieved March 27, 2022.
  9. ^ a b "Barbara Burtness Named Interim Associate Director for Diversity, Equity, and Inclusion at Yale Cancer Center". Yale University. June 22, 2021. Retrieved March 27, 2022.
  10. ^ "Yale Cancer Center presents Research awards during annual Conclave". Newswire. February 3, 2020. Retrieved March 27, 2022.
  11. ^ "Yale Cancer Center Awarded NIH SPORE Grant for Head and Neck Cancer Research". ASCO Post. October 25, 2020. Retrieved March 27, 2022.
  12. ^ Sharma, Manas (November 12, 2021). "Stand Up to Cancer announces new cancer research team co-led by Yale professor". Yale Daily News. Retrieved March 27, 2022.
  13. ^ "Barbara Burtness, MD, Named Chief Translational Research Officer for Yale Cancer Center and Smilow Cancer Hospital". Yale University. December 1, 2022. Retrieved April 29, 2024.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Barbara_Burtness&oldid=1221412456"